Exact Mass: 363.1348
Exact Mass Matches: 363.1348
Found 104 metabolites which its exact mass value is equals to given mass value 363.1348,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Methixene hydrochloride
Metixene hydrochloride hydrate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
4-[[5-Chloro-4-(2,4,6-trimethylanilino)pyrimidin-2-yl]amino]benzonitrile
4-({5-chloro-4-[(2,4,6-trimethylphenyl)amino]pyrimidin-2-yl}amino)benzonitrile
N-Biotinyl-4-aminobenzoic acid
4-(5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanamido)benzoic acid
Biotinyl-p-aminobenzoate
5-{2-hydroxy-1H,3ah,4H,6H,6ah-thieno[3,4-D]imidazol-6-yl}pentanoyl 4-aminobenzoic acid
2-[[[4-(3-Benzylcyclobutyl)-1,3-thiazol-2-yl]diazenyl]methyl]phenol
2-({2-[4-(3-benzylcyclobutyl)-1,3-thiazol-2-yl]diazen-1-yl}methyl)phenol
glioperazine B
glioperazine B
A member of the class of 2,5-diketopiperazines with an indole substituent. It is a microbial metabolite isolated from the mycelia of a liquid fermentation culture of the fungus, Bionectria byssicola and has been shown to exhibit antibacterial activity against Staphylococcus aureus.
(R)-2-(6-O-trans-2-butenoyl-beta-D-glucopyranosyloxy)-phenylacetonitrile
(R)-2-(6-O-trans-2-butenoyl-beta-D-glucopyranosyloxy)-phenylacetonitrile
Gly Asn Ser Ser
(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid
Gly Ser Asn Ser
(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid
Gly Ser Ser Asn
(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid
Asn Gly Ser Ser
(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxypropanamido]-3-hydroxypropanoic acid
Asn Ser Gly Ser
(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]acetamido}-3-hydroxypropanoic acid
Asn Ser Ser Gly
2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]acetic acid
Ser Gly Asn Ser
(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid
Ser Gly Ser Asn
(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid
Ser Asn Gly Ser
(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoic acid
Ser Asn Ser Gly
2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]acetic acid
Ser Ser Gly Asn
(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]acetamido}-3-carbamoylpropanoic acid
Ser Ser Asn Gly
2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]acetic acid
Serabelisib
Serabelisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D004791 - Enzyme Inhibitors
4-(4-BENZYLPIPERAZINO)-1H-INDOLE DIHYDROCHLORIDE MONOHYDRATE
4-(4-BENZYLPIPERAZINO)-1H-INDOLE DIHYDROCHLORIDE MONOHYDRATE
n-methoxy-n-methyl(triphenyl-phosphoranylidene)acetamide
n-methoxy-n-methyl(triphenyl-phosphoranylidene)acetamide
1-[2-(4-(Trifluoromethyl)phenyl)ethyl]-6,7-dimethoxy-3,4-dihydroisoquinoline
1-[2-(4-(Trifluoromethyl)phenyl)ethyl]-6,7-dimethoxy-3,4-dihydroisoquinoline
(4-(N-ISOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYL)BORONIC ACID
(4-(N-ISOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYL)BORONIC ACID
Thiphenamil hydrochloride
S-[2-(diethylamino)ethyl] alpha-phenylbenzeneethanethioate hydrochloride
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
antazoline
Antazoline phosphate
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents
GLY-PRO 4-METHOXY-BETA-NAPHTHYLAMIDE HYDROCHLORIDE
GLY-PRO 4-METHOXY-BETA-NAPHTHYLAMIDE HYDROCHLORIDE
4-[(5,6-DIHYDRO[2,3-BIPYRIDIN]-3(4H)-YLIDENE)METHYL]-N,N-DIMETHYLBENZENAMINE DIHYDROCHLORIDE
4-[(5,6-DIHYDRO[2,3-BIPYRIDIN]-3(4H)-YLIDENE)METHYL]-N,N-DIMETHYLBENZENAMINE DIHYDROCHLORIDE
(3-(N-Isopropyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid
(3-(N-Isopropyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid
3-(1-azepanylsulfonyl)-N-(3-isoxazolyl)-4-methylbenzamide
3-(1-azepanylsulfonyl)-N-(3-isoxazolyl)-4-methylbenzamide
{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone
{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone
3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Phe-OH
3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Phe-OH
(1R,2R,5S,8S,9S,10R,11R,12R,13S)-5,12,13-trihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
(1R,2R,5S,8S,9S,10R,11R,12R,13S)-5,12,13-trihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate
N-acetyl-alpha-D-muramoyl-L-alaninate
N-acetyl-alpha-D-muramoyl-L-alaninate
The carbohydrate acid derivative anion formed by loss of a proton from the carboxy group of N-acetyl-alpha-D-muramoyl-L-alanine; principal microspecies at pH 7.3.
3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanyl-L-phenylalanine
3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanyl-L-phenylalanine
5-(2-Oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoyl 4-aminobenzoate
5-(2-Oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoyl 4-aminobenzoate
phe-FMDP
phe-FMDP
A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-phenylalanine joined by peptide linkages.
2-[(1-Amino-1-oxopropan-2-yl)thio]-3-butyl-4-oxo-7-quinazolinecarboxylic acid methyl ester
2-[(1-Amino-1-oxopropan-2-yl)thio]-3-butyl-4-oxo-7-quinazolinecarboxylic acid methyl ester
1-(4,6-dimethoxy-1,3,5-triazin-2-yl)-N-(thiophen-2-ylmethyl)-4-piperidinecarboxamide
1-(4,6-dimethoxy-1,3,5-triazin-2-yl)-N-(thiophen-2-ylmethyl)-4-piperidinecarboxamide
3-[[4-[(4-chlorophenyl)methyl]-4-(hydroxymethyl)-1-piperidinyl]-oxomethyl]-4,5-dihydro-1H-pyridazin-6-one
3-[[4-[(4-chlorophenyl)methyl]-4-(hydroxymethyl)-1-piperidinyl]-oxomethyl]-4,5-dihydro-1H-pyridazin-6-one
N-[(E)-(5-Morpholin-4-ylthiophen-2-yl)methylideneamino]-N-phenylaniline
N-[(E)-(5-Morpholin-4-ylthiophen-2-yl)methylideneamino]-N-phenylaniline
N-[[(2S)-3beta-(Ethoxycarbonyl)aziridine-2alpha-yl]carbonyl]-Gly-Gly-OBzl
N-[[(2S)-3beta-(Ethoxycarbonyl)aziridine-2alpha-yl]carbonyl]-Gly-Gly-OBzl
hydron;1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;chloride;hydrate
hydron;1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;chloride;hydrate
3-(4-Morpholinyl)-2-phenyl-1-[4-(trifluoromethyl)phenyl]-1-propanone
3-(4-Morpholinyl)-2-phenyl-1-[4-(trifluoromethyl)phenyl]-1-propanone
SCD1 inhibitor-4
SCD1 inhibitor-4
SCD1 inhibitor-4 is a potent, orally active stearoylCoA desaturase-1 (SCD1) inhibitor. SCD1 inhibitor-4 can be used for the research of diabetes[1].
2-amino-3-[(triphenylmethyl)sulfanyl]propanoic acid
2-amino-3-[(triphenylmethyl)sulfanyl]propanoic acid
(2s,4s,5s,6s)-4,5-dihydroxy-6-[3-(c-hydroxycarbonimidoylmethyl)-4-methoxyindol-1-yl]oxane-2-carboximidic acid
(2s,4s,5s,6s)-4,5-dihydroxy-6-[3-(c-hydroxycarbonimidoylmethyl)-4-methoxyindol-1-yl]oxane-2-carboximidic acid
(2s)-2-({hydroxy[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid
(2s)-2-({hydroxy[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid
(2s,3s,4'r)-4'-(acetyloxy)-1'-methoxy-5'-methylidene-2'-oxo-3-[(1e)-prop-1-en-1-yl]-7-oxaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-5-en-6-yl acetate
(2s,3s,4'r)-4'-(acetyloxy)-1'-methoxy-5'-methylidene-2'-oxo-3-[(1e)-prop-1-en-1-yl]-7-oxaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-5-en-6-yl acetate
(1r,5's,6'r,7'ar)-5',6,6'-trihydroxy-4,5-dimethoxy-1'-methyl-3',5',6',7'a-tetrahydro-2'h-spiro[2-benzofuran-1,7'-indol]-3-one
(1r,5's,6'r,7'ar)-5',6,6'-trihydroxy-4,5-dimethoxy-1'-methyl-3',5',6',7'a-tetrahydro-2'h-spiro[2-benzofuran-1,7'-indol]-3-one
{6-[cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl}methyl but-2-enoate
{6-[cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl}methyl but-2-enoate
(3r)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(methylsulfanyl)methyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one
(3r)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(methylsulfanyl)methyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one
(1r,2s,6r,8s,9s,10r)-1,15-dihydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one
(1r,2s,6r,8s,9s,10r)-1,15-dihydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one
2-({hydroxy[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid
2-({hydroxy[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid
4'-(acetyloxy)-1'-methoxy-5'-methylidene-2'-oxo-3-(prop-1-en-1-yl)-7-oxaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-5-en-6-yl acetate
4'-(acetyloxy)-1'-methoxy-5'-methylidene-2'-oxo-3-(prop-1-en-1-yl)-7-oxaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-5-en-6-yl acetate
(3s,6s)-3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-6-methoxy-3-(methylsulfanyl)pyrazine-2,5-diol
(3s,6s)-3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-6-methoxy-3-(methylsulfanyl)pyrazine-2,5-diol
1,15-dihydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one
1,15-dihydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one
[(2r,3s,4s,5r,6r)-6-[(r)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-but-2-enoate
[(2r,3s,4s,5r,6r)-6-[(r)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-but-2-enoate
(3s)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(methylsulfanyl)methyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one
(3s)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(methylsulfanyl)methyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one
(2s)-2-[(2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propylidene)amino]-3-phenylpropanoic acid
(2s)-2-[(2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propylidene)amino]-3-phenylpropanoic acid
